News on NASH

Demand for liver transplant for NASH set to continue rising

Date: 24 Aug 2017

Story by Medical Xpress.

Given population obesity trends, the increase in the demand for liver transplantation (LT) for nonalcoholic steatohepatitis (NASH) noted since 2000 is expected to continue, according to a study published online Aug. 17 in Hepatology.

Read More

Low thyroid function predicts NASH, fibrosis in patients wit...

Date: 21 Aug 2017

Story by Healio.

“The prevalence of NASH and advanced fibrosis associated with [thyroid-stimulating hormone levels] was significantly higher in subjects with subclinical hypothyroidism than in those with normal thyroid function,” the researchers wrote.

Read More

NASH Biomarkers Market Analysis by Type, End-use and Segment...

Date: 21 Aug 2017

Read the article here.

The global non-alcoholic steatohepatitis (NASH) biomarkers market is expected to reach USD 2.09 billion by 2025, according to a new report by Grand View Research, Inc.

Read More

Organ crosstalk: Fatty liver can cause damage to other organ...

Date: 18 Aug 2017

Story by Science Daily.

According to the article, fatty liver increases the risk of chronic liver diseases (liver cirrhosis and liver cancer), as well as type 2 diabetes and cardiovascular diseases. How this happens is that the fatty liver increasingly produces glucose, unfavorable fats and proteins, such as the hepatokine fetuin-A, all of which it releases into the bloodstream and enters other organs, triggering adverse reactions.

Read More

Fibrosis, not NASH, predicts death, disease in fatty liver

Date: 15 Aug 2017

Story by Healio.

Nonalcoholic steatohepatitis did not increase the risk for liver-related morbidity, overall mortality or the time to development of severe liver disease in patients with nonalcoholic fatty liver disease, according to recently published data. However, fibrosis stage can be used as a significant marker.

Read More

NASH linked to early markers of hypertrophy

Date: 26 Jul 2017

Story by Healio.

Whether diastolic dysfunction similarly portends a risk of future [heart failure] among patients with NAFLD and/or NASH remains unknown, and we eagerly await well-designed, prospective studies to characterize this relationship.

Read More

AASLD releases NAFLD practice guides for screening, treatmen...

Date: 19 Jul 2017

Story by Healio.

In contrast to the incidence data, there is a significantly higher number of publications describing the prevalence of NAFLD in the general population.

Read More

Millions of people are living with a silent disease they've...

Date: 06 Jul 2017

Story by Business Insider.

NASH is set to surpass hepatitis as the biggest reason for liver transplants by 2020. That is seriously alarming!

Read More

NASH: KOL Insight [2017]

Date: 05 Jul 2017

By Report Buyer.

Key takeaway from experts on current study designs and endpoints, and the challenges facing novel therapies such as long-term safety, cost and diagnosis.

Read More

Fatty liver disease can be a silent killer

Date: 03 Jul 2017

Story by The New Paper, Singapore.

According to a report in Singapore's The New Paper (TNP), Non-alcoholic fatty liver disease - which can lead to liver cirrhosis or cancer - is on the rise in Singapore.

Read More

1 3 4 5 6